Immunology Lipidomics Services for Inflammatory Signaling

Immunology Lipidomics Services for Inflammatory Signaling

Creative Proteomics provides comprehensive immunology lipidomics services designed to define the molecular signatures of immune activation and resolution through the absolute quantification of bioactive lipid mediators. By utilizing high-sensitivity LC-MS/MS platforms, we enable researchers to monitor the dynamic transition between pro-inflammatory eicosanoids and specialized pro-resolving mediators (SPMs) such as resolvins and maresins. Our standardized RUO workflows ensure the detection of trace-level signaling lipids in complex matrices, providing the high-density data required to decode the lipid homeostasis mechanism in chronic inflammation and autoimmune disease research.

Key capabilities

  • Sub-picogram Sensitivity: Quantification of trace-level SPMs (Resolvins, Lipoxins, Protectins) at pg/mL concentrations.
  • Isomeric Separation: Advanced UHPLC-MRM/MS methods to distinguish structural isomers in the COX and LOX pathways.
  • Antioxidant Sample Integrity: Standardized cold-chain protocols with BHT/EDTA stabilization to prevent ex vivo autoxidation of polyunsaturated fatty acids.
Request Analysis

Submit Your Request Now

×

Our services have earned the trust of companies, schools, and organizations globally, and we remain dedicated to maintaining that trust.

Boston University
University at Buffalo
UMass Medical School
Hawaii Pacific University
Medizinische Fakultät
Louisiana State University
Nyulangone
Nature's Fynd
Dietary Supplement Manufacturer
  • Trends & Challenges
  • Integrated Solutions
  • Technical Advantages
  • Case Studies
  • FAQ

Situational Solution Matrix for Specialized Immunology Workflows

The complexity of the immune response requires a strategic analytical approach that matches the scale of the research goal. Whether in the early discovery phase or during the rigorous validation of a drug target, our solution matrix provides situational pathways for the most critical immunological research scenarios.

Macrophage M1/M2 Phenotype Transition

Situation & Goal

A drug development team is investigating a novel small molecule intended to induce a functional shift from pro-inflammatory (M1) to pro-resolving (M2) macrophages in a sepsis model. The goal is to quantify the absolute concentration of pro-resolving Lipoxin A4 versus pro-inflammatory PGE2 to confirm the phenotypic switch at the molecular level.

Recommended path: Discovery Bundle → Targeted Validation
Recommended services:
Lipoxins Targeted Lipidomics, Prostaglandins Targeted Lipidomics, Eicosanoid Analysis Service
What you will get

A detailed quantitative report on the COX/LOX pathway "class switch," providing definitive proof of macrophage polarization.

Tumor Microenvironment (TME) Immunosuppression

Situation & Goal

An onco-immunology team is researching how tumor-derived lipid mediators, such as specific prostaglandins or HETEs, suppress CD8+ T-cell activity and facilitate immune evasion. The goal is unbiased profiling of the tumor interstitial fluid and co-culture conditioned media to identify novel immunosuppressive lipid species.

Recommended path: Untargeted Discovery → Targeted Confirmation
Recommended services:
Untargeted Lipidomics, Eicosanoid Analysis Service
What you will get

Comprehensive lipidomic fingerprints with multivariate statistical validation (PCA/PLS-DA) to surface high-priority immunosuppressive candidates.

Allergic Airway Inflammation and LOX Pathway Analysis

Situation & Goal

Preclinical validation of a 5-LOX inhibitor or a leukotriene receptor antagonist in an ovalbumin-induced asthma model using bronchoalveolar lavage fluid (BALF). The goal is absolute quantification of cysteinyl leukotrienes (LTC4, LTD4, LTE4) and LTB4 to determine the IC50 and target engagement of the therapeutic.

Recommended path: Targeted Pathway Profiling
Recommended services:
Leukotrienes Targeted Lipidomics, Eicosanoid Analysis Service
What you will get

High-precision concentration data for all major leukotriene pathway metabolites, enabling robust pharmacokinetic/pharmacodynamic (PK/PD) modeling.

Chronic Inflammation and Resolution Kinetics

Situation & Goal

Investigating why chronic inflammation fails to resolve in rheumatoid arthritis or inflammatory bowel disease (IBD) patients, specifically looking for deficits in SPM biosynthesis. The goal is to perform a longitudinal time-course analysis of resolvins, protectins, and maresins in patient biofluids to identify "resolution gaps."

Recommended path: Targeted SPM Time-Course Analysis
Recommended services:
Resolvins Targeted Lipidomics, Maresins Targeted Lipidomics, Protectins D1 Targeted Lipidomics
What you will get

Kinetic curves of SPM production over time, identifying specific metabolic bottlenecks in the resolution phase.

Gut Microbiota-Immune Axis Modulation

Situation & Goal

Researching how microbial dysbiosis in the gut leads to systemic inflammation through the production of metabolic intermediates that cross the intestinal barrier. The goal is to simultaneously quantify microbiota-derived short-chain fatty acids (SCFAs) and mucosal eicosanoids to map the microbial-immune interface.

Recommended path: Dual Targeted Panel Analysis
Recommended services:
Short Chain Fatty Acids, Eicosanoid Analysis Service
What you will get

Integrated quantitative datasets linking gut microbial output to host immune signaling status.

Neuroinflammation and Microglia Homeostasis

Situation & Goal

Studying the role of lipid-driven neuroinflammation in neurodegenerative disease models (AD/PD) and the effect of pro-resolving lipids on microglial activation. The goal is to measure brain-specific protectins and inflammatory prostaglandins in cerebrospinal fluid (CSF) or brain tissue homogenates.

Recommended path: Targeted Neuro-lipidomic Profiling
Recommended services:
Protectins D1 Targeted Lipidomics, Resolvins Targeted Lipidomics, Cells Untargeted Lipidomics
What you will get

Specialized neuro-lipidomic data providing insights into the lipid-mediated regulation of neuroinflammation and CNS homeostasis.

Selected Case Studies

Client Publication: Freitas-Cortez, M. A., et al. (2025). Molecular Cancer. DOI: 10.1186/s12943-024-02198-2
Focus: FABP-Mediated Immune Evasion and Ferroptosis Resistance in Cancer.

Targeted Lipidomics for Immune Evasion Mechanisms

Research Goal

Onco-immunology research teams studying T-cell-mediated cytotoxicity and tumor metabolic evasion mechanisms needed to understand lipidomic shifts under immune pressure.

Method Used

Targeted lipidomics analysis of eicosanoids and oxylipins was performed on cancer cell lines co-cultured with CD8+ T-cells. Samples were analyzed using a Shimadzu Prominence HPLC system coupled to a Thermo Orbitrap mass spectrometer.

Result Obtained

The study revealed that cancer cells upregulate specific fatty acid binding proteins (FABPs) to avoid immune-induced lipid peroxidation. Targeted profiling demonstrated that FABP depletion sensitizes tumors to ferroptosis by altering the availability of polyunsaturated fatty acid substrates.

Heatmap showing differential lipid profiles in immunotherapy-sensitive vs. resistant cancer cells.
Figure 1A: Heatmap displaying differential lipidomic profiles between immunotherapy-sensitive and resistant cancer cell lines.
Client Publication: Kyathanahalli, C. N., et al. (2025). BJOG: An International Journal of Obstetrics & Gynaecology. DOI: 10.1111/1471-0528.18275
Focus: Lipidomic Cascades in Adolescent Mucosal Inflammation.

Lipidomic Signatures of Mucosal Inflammation

Research Goal

Clinical and translational researchers investigating chronic inflammation and mucosal immune dysregulation needed to identify diagnostic signatures of dysmenorrhea in patient cohorts.

Method Used

Adolescent menstrual effluent samples were subjected to targeted UHPLC-MS analysis for a broad panel of eicosanoids and oxylipins.

Result Obtained

The study identified an aberrant cascade of pro-inflammatory prostaglandins and oxylipins. This quantitative mapping provided novel insights into the lipid-driven mechanisms of pain and immune activation in mucosal environments.

Concentration comparison of key eicosanoids including PGE2 and PGF2α in menstrual effluent.
Figure 2: Comparative concentration analysis of key inflammatory lipid mediators (e.g., PGE2, PGF2α) in adolescent menstrual effluent.

Frequently Asked Questions

Why should immunologists profile lipid mediators alongside standard cytokine panels?
While cytokines dictate broad cellular instructions, lipid mediators reveal the immediate, functional execution of the immune response. Quantitative eicosanoid analysis provides a high-resolution snapshot of active signaling that cytokines cannot capture, particularly the switch between inflammation initiation and active resolution.
What is the functional difference between prostaglandins and resolving mediators like maresins?
Classic eicosanoids, like prostaglandins and leukotrienes, primarily initiate acute inflammation, pain, and vascular permeability. Specialized pro-resolving mediators (SPMs) are the metabolic "antidotes" that actively drive the resolution phase, clear cellular debris, and promote tissue repair.
How do you ensure the stability of fragile resolvins during sample prep?
We implement strict anti-oxidation protocols, including the immediate addition of antioxidants (BHT/EDTA) and low-temperature processing at 4°C. This prevents the degradation of immune response signaling lipids and ensures that measured concentrations reflect in vivo states.
What dynamic range is required for trace-level lipid mediators?
Lipid mediators can vary by several orders of magnitude. Our platforms provide a dynamic range exceeding 6 logs, ensuring that high-abundance prostaglandins do not mask the detection of low-abundance resolvins during specialized pro-resolving mediators (SPMs) analysis.
What is the minimum cell count for primary immune cell lipidomics?
For cell-specific profiling, we generally recommend 1–5 million cells per sample. However, with our highly sensitive targeted panels, we can often work with lower cell numbers depending on the specific pathway of interest.
Can you distinguish between structural isomers in the LOX pathway?
Yes. Our UHPLC methods are specifically optimized to separate structural isomers (e.g., LTB4 and its 6-trans-isomers). Precise isomeric separation is a core requirement for reliable inflammatory lipid mediator profiling.
Is serum or tissue more suitable for inflammation resolution research?
Serum reflects systemic signaling, while tissue biopsies or localized fluids (like BALF or synovial fluid) provide a more direct view of the site-specific resolution phase. Both matrices are compatible with our immunology lipidomics services.
Do you provide absolute quantification for specialized pro-resolving mediators (SPMs)?
Yes, we use stable isotope-labeled internal standards to provide true absolute quantification, which is essential for determining biological thresholds and comparing results across different immune models.

```

* Our services can only be used for research purposes and Not for clinical use.

Applications:


Online Inquiry

CONTACT US

Copyright © 2026 Creative Proteomics. All rights reserved.